Loading...

Anbio Biotechnology Class A Ordinary Shares

NNNN•NASDAQ
Healthcare
Medical - Instruments & Supplies
$26.30
$-0.97(-3.56%)
U.S. Market is Open • 10:19

Anbio Biotechnology Class A Ordinary Shares (NNNN) Stock Overview

Explore Anbio Biotechnology Class A Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio165.26
EPS (TTM)$0.15
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$26.64
3 Months$38.37
1 Year Target$53.77

NNNN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Anbio Biotechnology Class A Ordinary Shares (NNNN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $53.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 165.26 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.29%
5-Day Change
-1.41%
1-Month Change
17.94%
3-Month Change
-9.20%
6-Month Change
19.07%
Year-to-Date (YTD) Change
-9.05%
1-Year Change
308.21%
3-Year Change
374.003%
5-Year Change
374.003%
All-Time (Max) Change
374.003%

Contact Information

https://www.anbio.com
49 16 0962 47281
Wilhelm Gutbrod Str 21B, Frankfurt am Main, NaN, 60437

Company Facts

27 Employees
IPO DateFeb 19, 2025
CountryDE
Actively Trading

Frequently Asked Questions